Impact of modified microbiology reporting on the treatment of low-risk AmpC Enterobacterales infections: a multi-centre controlled interrupted time series study

Journal of Antimicrobial Chemotherapy · Published 2026-07-24 · DOI 10.1093/jac/dkag269

Authors (7)

Marie-Félixe Granger, Marion Elligsen, Janine McCready, Xena X Li, Robert A Kozak, Jerome A Leis, Philip W Lam

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Granger, M., Elligsen, M., McCready, J., et al. (2026). Impact of modified microbiology reporting on the treatment of low-risk AmpC Enterobacterales infections: a multi-centre controlled interrupted time series study. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag269

Related articles

• Novel EUCAST-approved quality control range for Escherichia coli ATCC® 25922 and cefoperazone 30 µg discs · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Antifungal susceptibility profiles of clinical and environmental Scedosporium and Lomentospora isolates from Taiwan: focus on olorofim activity and phylogenetic heterogeneity · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Mutation-driven alterations in the AcrB efflux pump modulate antibiotic resistance in Klebsiella pneumoniae · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Effect of adjunctive inhalation on the association between plasma AUC/MIC of polymyxin B and clinical efficacy in MDR gram-negative infections · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Antimicrobial resistance in Neisseria gonorrhoeae isolates at the Bangrak STIs Center, Bangkok, Thailand and WGS of antimicrobial-resistant isolates, 2018–23 · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Paediatric outpatient antibiotic utilization patterns and use of healthcare services before, during and after the COVID-19 pandemic: interrupted time series analysis using data from Norway and Japan · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Quinolones and risk of haemolysis in patients with glucose-6-phosphate dehydrogenase deficiency: a nationwide retrospective active-comparator cohort study · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Virological failure and resistance emergence during treatment with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir/lamivudine in people living with HIV without prior resistance mutations: a real-world study · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Predictive performance of an antibiotic precision dosing software program in critically ill adults with infection · Journal of Antimicrobial Chemotherapy · 2026 · Same journal
• Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study-right-to-reply · Journal of Antimicrobial Chemotherapy · 2026 · Same journal